Skip to main content

Table 3 MicroRNAs differentiating between basal-like breast cancer subgroups

From: Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

miRNA

Probe ID

p-value

hsa-put-miR-92597

CRINCR2000005427

2.8·10−4

hsa-miR-361-3p

A_25_P00012305

2.8·10−4

hsa-miR-342-3p

A_25_P00012357

4·10−4

hsa-miR-140-3p

A_25_P00012177

1.3·10−4

hsa-miR-34a

A_25_P00012086

4.9·10−3

hsa-miR-22

A_25_P00010204

6.3·10−3

hsa-miR-142-5p

A_25_P00014844

2·10−4

hsa-miR-142-3p

A_25_P00011016

2.2·10−3

hsa-miR-155

A_25_P00012271

6.3·10−6

hsa-miR-342-5p

A_25_P00012354

2·10−7

hsa-miR-150

A_25_P00014847

8.7·10−6

hsa-put-miR-4391

CRINCR2000005084

1.2·10−4

hsa-miR-29c

A_25_P00012274

6.7·10−3

hsa-miR-29c*

A_25_P00013484

5.6·10−4

hsa-miR-29a

A_25_P00012013

4.8·10−3

hsa-miR-19b-1*

A_25_P00013163

5.3·10−4

hsa-miR-17*

A_25_P00013151

5·10−4

hsa-miR-17

A_25_P00013841

1.9·10−3

hsa-miR-200c*

A_25_P00013469

1.8·10−4

  1. The miRNAs differentially expressed in Basal I and II subgroups are listed in this table, with the corresponding p-value in the METABRIC training set. Probes above the mid-line indicate the miRNAs over-expressed in Basal I, while those below are over-expressed in Basal II. Probe IDs correspond to the Agilent platform